Bank of America
BNTC icon

Bank of America’s Benitec Biopharma BNTC Stock Holding History

Bank of America’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$185K Buy
17,376
+5,251
+43% +$60.8K ﹤0.01% 5384
2025
Q4 		$163K Buy
12,125
+4,565
+60% +$63.1K ﹤0.01% 5433
2025
Q3 		$106K Buy
7,560
+681
+10% +$8.69K ﹤0.01% 6571
2025
Q2 		$80.5K Buy
6,879
+6,587
+2,256% +$92.2K ﹤0.01% 6622
2025
Q1 		$3.8K Buy
292
+144
+97% +$1.74K ﹤0.01% 7259
2024
Q4 		$1.87K Buy
148
+80
+118% +$864 ﹤0.01% 7203
2024
Q3 		$625 Sell
68
-9
-12% -$81 ﹤0.01% 7335
2024
Q2 		$538 Buy
+77
New +$568 ﹤0.01% 7345
2021
Q4 		– Sell
-5
Closed – – 8229
2021
Q3 		$0 Buy
+5
New +$328 ﹤0.01% 8111
2018
Q2 		– Sell
-10
Closed -$8K – 7087
2018
Q1 		$8K Hold
10
– – ﹤0.01% 6661
2017
Q4 		$8K Hold
10
– – ﹤0.01% 6650
2017
Q3 		$6K Buy
+10
New +$5.34K ﹤0.01% 6667

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Bank of America's BNTC Position: Q1 2026 in Review

Bank of America increased its Benitec Biopharma (BNTC) stake by 43% in Q1 2026, buying an estimated $60.8K and bringing the position to 17,376 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #5384.

Bank of America first reported a position in BNTC in Q3 2017 and has held it in 12 quarters since. 88 funds tracked by Wall St. Rank hold BNTC as of Q1 2026.

  • Bank of America held 17,376 shares of Benitec Biopharma worth $185K as of Q1 2026.
  • Bank of America bought 5,251 Benitec Biopharma shares in Q1 2026, an estimated $60.8K.
  • Benitec Biopharma made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5384 holding.
  • Bank of America first reported a position in Benitec Biopharma in Q3 2017 and has held it in 12 quarters since.
  • 88 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.